In situ characterization of β-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy

Biophysical Journal

Volumn 71, Issue 4, 1996, Pages 1672-1679

  Choo, Lin P'ing ^a,b   Wetzel, David L ^c   Halliday, William C ^d   Jackson, Michael ^a   LeVine, Steven M ^e   Mantsch, Henry H ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KANSAS STATE UNIVERSITY   (United States)

^d HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GRAY MATTER; HUMAN; HUMAN TISSUE; HYDROGEN BOND; INFRARED SPECTROSCOPY; PROTEIN DETERMINATION; SYNCHROTRON;

EID: 0029839357     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79411-0     Document Type: Article

References (28)

1. Barrow, C. J., and M. G. Zagorski. 1991. Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science. 253:179-182.
2. Choo, L-P., M. Jackson, W. C. Halliday, and H. H. Mantsch. 1993. Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system. Biochim. Biophys. Acta. 1182:333-337.
3. Choo, L.-P., J. R. Mansfield, N. Pizzi, R. L. Somorjai, M. Jackson, W. C. Halliday, and H. H. Mantsch. 1995. Infrared spectra of human central nervous system tissue: diagnosis of Alzheimer's disease by multivariate analyses. Biospectroscopy. 1:141-148.
4. Fabian, H., L.-P. Choo, G. I. Szendrei, M. Jackson, W. C. Halliday, L. Ötvös, and H. H. Mantsch. 1993. Infrared spectroscopic characterization of Alzheimer plaques. Appl. Spectrosc. 47:1513-1518.
5. Fabian, H., G. I. Szendrei, H. H. Mantsch, B. D. Greenberg, and L. L. Ötvös. 1994. Synthetic post-translationally modified human Aβ peptide exhibits a markedly increased tendency to form β-pleated sheets in vitro. Eur. J. Biochem. 221:959-964.
6. Fraser, P. E., L. Lévesque, and D. R. McLachlan. 1993. Biochemistry of Alzheimer disease amyloid plaques. Clin. Biochem. 26:339-349.
7. Fraser, P. E., D. R. McLachlan, W. K. Surewicz, C. A. Mizzen, A. D. Snow, J. T. Nguyen, and D. A. Kirschner. 1994. Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues. J. Mol. Biol. 244:64-73.
8. Fraser, P. E., J. T. Nguyen, H. Inouye, W. K. Surewicz, D. J. Selkoe, M. B. Podlisny, and D. A. Kirschner. 1992. Fibril formation by primate, rodent, and Dutch-hemmoragic analogues of Alzheimer amyloid β-protein. Biochemistry. 31:10716-10723.
9. Fraser, P. E., J. T. Nguyen, W. K. Surewicz, and D. A. Kirschner. 1991. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60:1190-1201.
10. Hill, S. L., K. Krishnan, and J. R. Powell. 1989. Infrared microtransmission and microreflectance of biological systems. Proc. SPIE. 1145:400-402.
11. Inouye, H., P. E. Fraser, and D. A. Kirschner. 1993. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: analysis by x-ray diffraction. Biophys. J. 64:502-519.
12. Jackson, M., and H. H. Mantsch. 1993. Biomembrane structure from FT-IR spectroscopy. Spectrochim. Acta Rev. 15:53-69.
13. Jackson, M., and H. H. Mantsch. 1995. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30:95-120.
14. Jarrett, J. T., E. P. Berger, and P. T. Lansbury. 1993. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:4693-4697.
15. Katzman, R., and J. E. Jackson. 1991. Alzheimer disease: basic and clinical advances. J. Am. Ger. Soc. 39:516-525.
16. Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1105.
17. Kodali, D. R., D. M. Small, J. Powell, and K. Krishnan. 1991. Infrared micro-imaging of atherosclerotic arteries. Appl. Spectrosc. 45:1310-1317.
18. Maury, C. P. J. 1995. Biology of disease. Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab. Invest. 72:4-16.
19. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34:939-944.
20. Mirra, S. S., M. N. Hart, and R. D. Terry. 1993. Making the diagnosis of Alzheimer's disease. Arch. Pathol. Lab. Med. 117:132-144.
21. Ötvös, L., G. I. Szendrei, V. M.-Y. Lee, and H. H. Mantsch. 1993. Human and rodent Alzheimer β-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur. J. Biochem. 211:249-257.
22. Reffner, J. A., P. A. Martoglio, and G. P. Williams. 1995. Fourier transform infrared microscopical analysis with synchrotron radiation: the microscope optics and system performance. Rev. Sci. Instrum. 66:1298-1302.
23. Selkoe, D. J. 1994. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:438-447.
24. Sisodia, S. S., and D. L. Price. 1995. Role of β-amyioid protein in Alzheimer's disease. FASEB J. 9:366-370.
25. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1977-1981.
26. Wetzel, D. L., and S. M. LeVine. 1993. In situ FT-IR microspectroscopy and mapping of normal brain tissue. Spectroscopy. 7:40-45.
27. Yankner, B. A., L. R. Dawes, S. Fisher, L. Villa-Komaroff, M. L. Oster-Granite, and R. L. Neve. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:417-420.
28. Zagorski, M. G., and C. J. Barrow. 1992. NMR studies of amyloid β-peptides: proton assignments, secondary structure, and mechanism of an α-helix β-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry. 31:5621-5631.